Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
Market Analysis and Insights: Global Drug Eluting Beads Market
The global Drug Eluting Beads market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Drug Eluting Beads Scope and Segment
The global Drug Eluting Beads market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Beads market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oncozene Beads
Quadra Sphere
LC Beads
Others
By the end users/application, this report covers the following segments
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers
Competitive Landscape:
The report provides a list of all the key players in the Drug Eluting Beads market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Drug Eluting Beads key manufacturers in this market include:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
Market Analysis and Insights: Global Drug Eluting Beads Market
The global Drug Eluting Beads market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Drug Eluting Beads Scope and Segment
The global Drug Eluting Beads market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Beads market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oncozene Beads
Quadra Sphere
LC Beads
Others
By the end users/application, this report covers the following segments
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers
Competitive Landscape:
The report provides a list of all the key players in the Drug Eluting Beads market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Drug Eluting Beads key manufacturers in this market include:
Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
1 Drug Eluting Beads Market Overview
1.1 Drug Eluting Beads Product Overview
1.2 Drug Eluting Beads Market Segment by Type
1.2.1 Oncozene Beads
1.2.2 Quadra Sphere
1.2.3 LC Beads
1.2.4 Others
1.3 Global Drug Eluting Beads Market Size by Type
1.3.1 Global Drug Eluting Beads Market Size Overview by Type (2016-2027)
1.3.2 Global Drug Eluting Beads Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Drug Eluting Beads Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Drug Eluting Beads Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Drug Eluting Beads Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Drug Eluting Beads Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Drug Eluting Beads Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Drug Eluting Beads Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Drug Eluting Beads Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.2 Europe Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Drug Eluting Beads Sales Breakdown by Type (2016-2021)
2 Global Drug Eluting Beads Market Competition by Company
2.1 Global Top Players by Drug Eluting Beads Sales (2016-2021)
2.2 Global Top Players by Drug Eluting Beads Revenue (2016-2021)
2.3 Global Top Players Drug Eluting Beads Price (2016-2021)
2.4 Global Top Manufacturers Drug Eluting Beads Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Beads Market Competitive Situation and Trends
2.5.1 Drug Eluting Beads Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Beads Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Beads as of 2020)
2.7 Date of Key Manufacturers Enter into Drug Eluting Beads Market
2.8 Key Manufacturers Drug Eluting Beads Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Beads Status and Outlook by Region
3.1 Global Drug Eluting Beads Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Drug Eluting Beads Historic Market Size by Region
3.2.1 Global Drug Eluting Beads Sales in Volume by Region (2016-2021)
3.2.2 Global Drug Eluting Beads Sales in Value by Region (2016-2021)
3.2.3 Global Drug Eluting Beads Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Drug Eluting Beads Forecasted Market Size by Region
3.3.1 Global Drug Eluting Beads Sales in Volume by Region (2022-2027)
3.3.2 Global Drug Eluting Beads Sales in Value by Region (2022-2027)
3.3.3 Global Drug Eluting Beads Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Drug Eluting Beads by Application
4.1 Drug Eluting Beads Market Segment by Application
4.1.1 Hospitals
4.1.2 Specialized Clinics
4.1.3 Research Centers
4.1.4 Ambulatory Surgical Centers
4.2 Global Drug Eluting Beads Market Size by Application
4.2.1 Global Drug Eluting Beads Market Size Overview by Application (2016-2027)
4.2.2 Global Drug Eluting Beads Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Drug Eluting Beads Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Drug Eluting Beads Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Drug Eluting Beads Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Drug Eluting Beads Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Drug Eluting Beads Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Drug Eluting Beads Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Drug Eluting Beads Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.2 Europe Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Drug Eluting Beads Sales Breakdown by Application (2016-2021)
5 North America Drug Eluting Beads by Country
5.1 North America Drug Eluting Beads Historic Market Size by Country
5.1.1 North America Drug Eluting Beads Sales in Volume by Country (2016-2021)
5.1.2 North America Drug Eluting Beads Sales in Value by Country (2016-2021)
5.2 North America Drug Eluting Beads Forecasted Market Size by Country
5.2.1 North America Drug Eluting Beads Sales in Volume by Country (2022-2027)
5.2.2 North America Drug Eluting Beads Sales in Value by Country (2022-2027)
6 Europe Drug Eluting Beads by Country
6.1 Europe Drug Eluting Beads Historic Market Size by Country
6.1.1 Europe Drug Eluting Beads Sales in Volume by Country (2016-2021)
6.1.2 Europe Drug Eluting Beads Sales in Value by Country (2016-2021)
6.2 Europe Drug Eluting Beads Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Beads Sales in Volume by Country (2022-2027)
6.2.2 Europe Drug Eluting Beads Sales in Value by Country (2022-2027)
7 Asia-Pacific Drug Eluting Beads by Region
7.1 Asia-Pacific Drug Eluting Beads Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Beads Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Drug Eluting Beads Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Drug Eluting Beads Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Beads Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Drug Eluting Beads Sales in Value by Region (2022-2027)
8 Latin America Drug Eluting Beads by Country
8.1 Latin America Drug Eluting Beads Historic Market Size by Country
8.1.1 Latin America Drug Eluting Beads Sales in Volume by Country (2016-2021)
8.1.2 Latin America Drug Eluting Beads Sales in Value by Country (2016-2021)
8.2 Latin America Drug Eluting Beads Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Beads Sales in Volume by Country (2022-2027)
8.2.2 Latin America Drug Eluting Beads Sales in Value by Country (2022-2027)
9 Middle East and Africa Drug Eluting Beads by Country
9.1 Middle East and Africa Drug Eluting Beads Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Beads Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Drug Eluting Beads Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Drug Eluting Beads Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Beads Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Drug Eluting Beads Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Drug Eluting Beads Business
10.1 Biocompatibles
10.1.1 Biocompatibles Corporation Information
10.1.2 Biocompatibles Introduction and Business Overview
10.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Biocompatibles Drug Eluting Beads Products Offered
10.1.5 Biocompatibles Recent Development
10.2 BTG International
10.2.1 BTG International Corporation Information
10.2.2 BTG International Introduction and Business Overview
10.2.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Biocompatibles Drug Eluting Beads Products Offered
10.2.5 BTG International Recent Development
10.3 Merit Medical Systems
10.3.1 Merit Medical Systems Corporation Information
10.3.2 Merit Medical Systems Introduction and Business Overview
10.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Merit Medical Systems Drug Eluting Beads Products Offered
10.3.5 Merit Medical Systems Recent Development
10.4 CeloNova BioSciences
10.4.1 CeloNova BioSciences Corporation Information
10.4.2 CeloNova BioSciences Introduction and Business Overview
10.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.4.4 CeloNova BioSciences Drug Eluting Beads Products Offered
10.4.5 CeloNova BioSciences Recent Development
10.5 ABK Biomedical
10.5.1 ABK Biomedical Corporation Information
10.5.2 ABK Biomedical Introduction and Business Overview
10.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.5.4 ABK Biomedical Drug Eluting Beads Products Offered
10.5.5 ABK Biomedical Recent Development
10.6 Boston Scientific
10.6.1 Boston Scientific Corporation Information
10.6.2 Boston Scientific Introduction and Business Overview
10.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Boston Scientific Drug Eluting Beads Products Offered
10.6.5 Boston Scientific Recent Development
10.7 Medtronic
10.7.1 Medtronic Corporation Information
10.7.2 Medtronic Introduction and Business Overview
10.7.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Medtronic Drug Eluting Beads Products Offered
10.7.5 Medtronic Recent Development
10.8 Merit Medical Systems
10.8.1 Merit Medical Systems Corporation Information
10.8.2 Merit Medical Systems Introduction and Business Overview
10.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merit Medical Systems Drug Eluting Beads Products Offered
10.8.5 Merit Medical Systems Recent Development
10.9 Surefire Medical
10.9.1 Surefire Medical Corporation Information
10.9.2 Surefire Medical Introduction and Business Overview
10.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Surefire Medical Drug Eluting Beads Products Offered
10.9.5 Surefire Medical Recent Development
10.10 Terumo
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Drug Eluting Beads Product Category, Application and Specification
10.10.3 Terumo Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Terumo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Beads Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Beads Industrial Chain Analysis
11.4 Drug Eluting Beads Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Beads Distributors
12.3 Drug Eluting Beads Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Drug Eluting Beads Product Overview
1.2 Drug Eluting Beads Market Segment by Type
1.2.1 Oncozene Beads
1.2.2 Quadra Sphere
1.2.3 LC Beads
1.2.4 Others
1.3 Global Drug Eluting Beads Market Size by Type
1.3.1 Global Drug Eluting Beads Market Size Overview by Type (2016-2027)
1.3.2 Global Drug Eluting Beads Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Drug Eluting Beads Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Drug Eluting Beads Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Drug Eluting Beads Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Drug Eluting Beads Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Drug Eluting Beads Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Drug Eluting Beads Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Drug Eluting Beads Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.2 Europe Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Drug Eluting Beads Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Drug Eluting Beads Sales Breakdown by Type (2016-2021)
2 Global Drug Eluting Beads Market Competition by Company
2.1 Global Top Players by Drug Eluting Beads Sales (2016-2021)
2.2 Global Top Players by Drug Eluting Beads Revenue (2016-2021)
2.3 Global Top Players Drug Eluting Beads Price (2016-2021)
2.4 Global Top Manufacturers Drug Eluting Beads Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Beads Market Competitive Situation and Trends
2.5.1 Drug Eluting Beads Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Beads Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Beads as of 2020)
2.7 Date of Key Manufacturers Enter into Drug Eluting Beads Market
2.8 Key Manufacturers Drug Eluting Beads Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Beads Status and Outlook by Region
3.1 Global Drug Eluting Beads Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Drug Eluting Beads Historic Market Size by Region
3.2.1 Global Drug Eluting Beads Sales in Volume by Region (2016-2021)
3.2.2 Global Drug Eluting Beads Sales in Value by Region (2016-2021)
3.2.3 Global Drug Eluting Beads Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Drug Eluting Beads Forecasted Market Size by Region
3.3.1 Global Drug Eluting Beads Sales in Volume by Region (2022-2027)
3.3.2 Global Drug Eluting Beads Sales in Value by Region (2022-2027)
3.3.3 Global Drug Eluting Beads Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Drug Eluting Beads by Application
4.1 Drug Eluting Beads Market Segment by Application
4.1.1 Hospitals
4.1.2 Specialized Clinics
4.1.3 Research Centers
4.1.4 Ambulatory Surgical Centers
4.2 Global Drug Eluting Beads Market Size by Application
4.2.1 Global Drug Eluting Beads Market Size Overview by Application (2016-2027)
4.2.2 Global Drug Eluting Beads Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Drug Eluting Beads Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Drug Eluting Beads Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Drug Eluting Beads Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Drug Eluting Beads Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Drug Eluting Beads Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Drug Eluting Beads Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Drug Eluting Beads Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.2 Europe Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Drug Eluting Beads Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Drug Eluting Beads Sales Breakdown by Application (2016-2021)
5 North America Drug Eluting Beads by Country
5.1 North America Drug Eluting Beads Historic Market Size by Country
5.1.1 North America Drug Eluting Beads Sales in Volume by Country (2016-2021)
5.1.2 North America Drug Eluting Beads Sales in Value by Country (2016-2021)
5.2 North America Drug Eluting Beads Forecasted Market Size by Country
5.2.1 North America Drug Eluting Beads Sales in Volume by Country (2022-2027)
5.2.2 North America Drug Eluting Beads Sales in Value by Country (2022-2027)
6 Europe Drug Eluting Beads by Country
6.1 Europe Drug Eluting Beads Historic Market Size by Country
6.1.1 Europe Drug Eluting Beads Sales in Volume by Country (2016-2021)
6.1.2 Europe Drug Eluting Beads Sales in Value by Country (2016-2021)
6.2 Europe Drug Eluting Beads Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Beads Sales in Volume by Country (2022-2027)
6.2.2 Europe Drug Eluting Beads Sales in Value by Country (2022-2027)
7 Asia-Pacific Drug Eluting Beads by Region
7.1 Asia-Pacific Drug Eluting Beads Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Beads Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Drug Eluting Beads Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Drug Eluting Beads Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Beads Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Drug Eluting Beads Sales in Value by Region (2022-2027)
8 Latin America Drug Eluting Beads by Country
8.1 Latin America Drug Eluting Beads Historic Market Size by Country
8.1.1 Latin America Drug Eluting Beads Sales in Volume by Country (2016-2021)
8.1.2 Latin America Drug Eluting Beads Sales in Value by Country (2016-2021)
8.2 Latin America Drug Eluting Beads Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Beads Sales in Volume by Country (2022-2027)
8.2.2 Latin America Drug Eluting Beads Sales in Value by Country (2022-2027)
9 Middle East and Africa Drug Eluting Beads by Country
9.1 Middle East and Africa Drug Eluting Beads Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Beads Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Drug Eluting Beads Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Drug Eluting Beads Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Beads Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Drug Eluting Beads Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Drug Eluting Beads Business
10.1 Biocompatibles
10.1.1 Biocompatibles Corporation Information
10.1.2 Biocompatibles Introduction and Business Overview
10.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Biocompatibles Drug Eluting Beads Products Offered
10.1.5 Biocompatibles Recent Development
10.2 BTG International
10.2.1 BTG International Corporation Information
10.2.2 BTG International Introduction and Business Overview
10.2.3 BTG International Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Biocompatibles Drug Eluting Beads Products Offered
10.2.5 BTG International Recent Development
10.3 Merit Medical Systems
10.3.1 Merit Medical Systems Corporation Information
10.3.2 Merit Medical Systems Introduction and Business Overview
10.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Merit Medical Systems Drug Eluting Beads Products Offered
10.3.5 Merit Medical Systems Recent Development
10.4 CeloNova BioSciences
10.4.1 CeloNova BioSciences Corporation Information
10.4.2 CeloNova BioSciences Introduction and Business Overview
10.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.4.4 CeloNova BioSciences Drug Eluting Beads Products Offered
10.4.5 CeloNova BioSciences Recent Development
10.5 ABK Biomedical
10.5.1 ABK Biomedical Corporation Information
10.5.2 ABK Biomedical Introduction and Business Overview
10.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.5.4 ABK Biomedical Drug Eluting Beads Products Offered
10.5.5 ABK Biomedical Recent Development
10.6 Boston Scientific
10.6.1 Boston Scientific Corporation Information
10.6.2 Boston Scientific Introduction and Business Overview
10.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Boston Scientific Drug Eluting Beads Products Offered
10.6.5 Boston Scientific Recent Development
10.7 Medtronic
10.7.1 Medtronic Corporation Information
10.7.2 Medtronic Introduction and Business Overview
10.7.3 Medtronic Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Medtronic Drug Eluting Beads Products Offered
10.7.5 Medtronic Recent Development
10.8 Merit Medical Systems
10.8.1 Merit Medical Systems Corporation Information
10.8.2 Merit Medical Systems Introduction and Business Overview
10.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merit Medical Systems Drug Eluting Beads Products Offered
10.8.5 Merit Medical Systems Recent Development
10.9 Surefire Medical
10.9.1 Surefire Medical Corporation Information
10.9.2 Surefire Medical Introduction and Business Overview
10.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Surefire Medical Drug Eluting Beads Products Offered
10.9.5 Surefire Medical Recent Development
10.10 Terumo
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Drug Eluting Beads Product Category, Application and Specification
10.10.3 Terumo Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Terumo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Beads Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Beads Industrial Chain Analysis
11.4 Drug Eluting Beads Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Beads Distributors
12.3 Drug Eluting Beads Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
